Search

everythinglearnresearchcommunity

for

Search:↓

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Most patients improved with oral contraceptives, but some needed additional treatment.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Tissue stiffness affects hair follicle regeneration, and Twist1 is a key regulator.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

Acne is an important sign of androgen excess disorders in women.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Men prefer less invasive cosmetic procedures and need different treatment approaches than women.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Human body's immune cells are more common in the layer of fat just beneath the skin than in deeper fat layers.

Hair follicle regeneration may slow tumor growth.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

Sorafenib after liver surgery may increase survival for some liver cancer patients.

Early hair whitening may indicate a higher risk of heart disease in young and middle-aged men.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Tamoxifen caused hair loss in a 52-year-old woman.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.